Loading data
GALTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 14.29 m USD | 36.57 m USD | 32.13 m USD | 31.74 m USD | 23.82 m USD |
| Operating profit | -20.09 m USD | -42.43 m USD | -38.07 m USD | -38.35 m USD | -30.18 m USD |
| Interest expense | — | — | 2.79 m USD | 1.03 m USD | 489 k USD |
| Income tax expense | 0 USD | 0 USD | — | — | — |
| Net income (reported basis) | -30.84 m USD | -47.05 m USD | -41.07 m USD | -38.78 m USD | -30.53 m USD |
| Net income attributable to common shareholders | -31 m USD | -47.2 m USD | -44.8 m USD | -38.9 m USD | -30.7 m USD |
| Basic earnings per share | -0.48 USD/share | -0.76 USD/share | -0.74 USD/share | -0.65 USD/share | -0.52 USD/share |
| Diluted earnings per share | -0.48 USD/share | -0.76 USD/share | -0.74 USD/share | -0.65 USD/share | -0.52 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.